医疗特长：从事消化内科临床工作近30年，对炎症性肠病（克罗恩病、溃疡性结肠炎）、罕见病（遗传性血管性水肿、IgG4相关性疾病、家族性地中海热、糖原累积病等）及自身免疫性肠病、乳糜泻、PD-1相关免疫性肠炎、蛋白丢失性肠病、P-J综合征（黑斑息肉病）等小肠疑难疾病的诊断治疗有较丰富的经验，擅长小肠镜、胶囊内镜及超声内镜，主要研究方向为炎症性肠病、罕见病及小肠疾病。研究方向：炎症性肠病（克罗恩病、溃疡性结肠炎）、罕见病、小肠疾病、小肠镜诊治技术主要教育和工作经历：1994年毕业于中山医科大学临床医学系，毕业后一直在中山大学附属第一医院消化内科工作，2005-2006年到香港威尔斯亲王医院进修，2007年获中山大学内科学博士学位。社会兼职：1.中华医学会消化病学分会炎症性肠病学组心理协作组委员；2.中华医学会消化内镜学分会胶囊内镜协作组委员；3.广东省医学会消化病学分会炎症性肠病学组副组长；4.广东省医师学会消化内镜学医师分会小肠内镜专业组副组长；5.广东省医师协会消化科医师学分会委员；6.中华炎性肠病杂志青年学术组副组长论著：1.Zhang SH, Chen BL(共同第一作者),Wang BM,Chen H,Li Y，Cao Q,Chen MH.Effect of induction therapy with Olamkicept vs placebo on clinical response in patient with active ulcerative colitis.JAMA.2023.329(9):1-102.Chen BL,Zhong J,LiXL,Pan F,Ding TJ,Zhang Y,Chen H,Liu F,ZhangZY, Zhang L,Rafal Drozda,Oleksandr Oliinyk Aik Han Goh Chen X Sun X; David T Rubin, William J Sandborn,Chen MH; Efficacy and Safety of Ivarmacitinib in Patients With Moderate-to-Severe, Active, Ulcerative Colitis: A Phase II Study, Gastroenterology, 20223.Zhuang XJ,Chen BL(共同第一作者), Huang SS,Han J,Zhou GS,Xu S,Chen MH,Zeng ZR,Zhang SH. Hypermethylation of miR-145 promoter-mediated SOX9-CLDN8 pathway regulates intestinal mucosal barrier in Crohn\'s disease,EBioMedicine, 2022, 764.Chen BL,Gao X,Zhong J,Ren JL,Zhu X, Liu ZJ,Wu KC,Jasmina Kalabic,Yu ZQ,Bidan Huang,Nisha Kwatra,Thao Doan,Anne M. Robinson,Chen HM. Efficacy and safety of adalimumab in Chinese patients with moderately to severely active Crohn\'s disease: results from a randomized trial, Therap Adv Gastroenterol, 2020, 13.5.Feng T,Chen BL(共同第一作者),Bella Ungar et al. Association of Infliximab Levels With Mucosal Healing Is Time-Dependent in Crohn’s Disease: Higher Drug Exposure Is Required Postinduction Than During Maintenance Treatment. Inflamm Bowel Dis 2019.25 (11):1813-18216.Feng T,Chen B(共同第一作者),Li L, Huang S, Ben-Horin S, Qiu Y, Feng R, Li M, Mao R, He Y, Zeng Z, Zhang S , Chen M. Serum Interleukin 9 Levels Predict Disease Severity and the Clinical Efficacy of Infliximab in Patients with Crohn\'s Disease. Inflamm Bowel Dis, 2017, 23 (10): 1817-1824.7.Qiu Y,Chen BL(共同第一作者), Mao R, Zhang SH, He Y, Zeng ZR, Ben-Horin S, Chen MH .Systematic Review with Meta-Analysis: Loss of Response and Requirement of anti-TNFalpha Dose Intensification in Crohn\'s Disease. J Gastroenterol, 2017, 52 (5): 535-554.专著：克罗恩病--基础研究与临床实践溃疡性结肠炎--基础研究与临床实践其他主要工作成绩（比如获奖情况）：无